World News
-
Mission Therapeutics team up with AbbVie against Alzheimer's, Parkinson’s
World | News | 0 Comment | 16 Nov, 2018
Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes...Read more
-
Vyera to Initiate Phase 1 Study of NCE for Toxoplasmosis
World | News | 0 Comment | 16 Nov, 2018
Vyera Pharmaceuticals, LLC has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...Read more
-
FDA ratcheting up pressure on flavored tobacco and e-cig products
World | News | 0 Comment | 16 Nov, 2018
Singapore - Citing the sharp rise in youth use of e-cigarettes, FDA Commissioner Scott Gottlieb, M.D. announces&nbs...Read more
-
Boston Scientific to restructure in 2019
World | News | 0 Comment | 16 Nov, 2018
Singapore - Aimed at trimming annual operating expenses by $100M - 150M and boosting performance, Boston Scientific will...Read more
-
ADC Bio secures additional equity round investment
World | News | 0 Comment | 15 Nov, 2018
ADC Biotechnology (ADC Bio), announces that it has secured additional funding of £2.5 million from existing invest...Read more
-
Exscientia acquires Kinetic Discovery to build 'full stack' AI-driven drug discovery capabilities
World | News | 0 Comment | 15 Nov, 2018
Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...Read more
-
J&J cleared of liability in talc cancer case by California jury
World | News | 0 Comment | 15 Nov, 2018
Singapore - A California jury clears Johnson & Johnson of liability in a case involving a woman who alleged tha...Read more
-
Nashville Biosciences enters into agreement with BC Platforms
World | News | 0 Comment | 15 Nov, 2018
Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...Read more
-
Sandoz to focus on more lucrative markets
World | News | 0 Comment | 15 Nov, 2018
Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimil...Read more
-
Grunenthal establishes commercial footprint in the US
World | News | 0 Comment | 14 Nov, 2018
Grunenthal has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ...Read more
-
VIB accelerates therapeutic biologics discovery with Geneious Biologics
World | News | 0 Comment | 14 Nov, 2018
Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like m...Read more
-
Amgen's Repatha shows durable treatment effect in long-term study
World | News | 0 Comment | 13 Nov, 2018
Singapore – Amgen announced the final results from a five-year open-label study evaluating the abil...Read more
-
Athenahealth sale sealed for $5.5B
World | News | 0 Comment | 12 Nov, 2018
Singapore – P-E player Veritas Capital and hedge fund Elliott Management have teamed to purchase Athenahealth...Read more
-
WHO uncovers big variations in antibiotics consumption
World | News | 0 Comment | 12 Nov, 2018
According to a recent survey conducted by the World Health Organization (WHO), antibiotics are used far more in some cou...Read more
-
Thermo Fisher brings New Director to Board
World | News | 0 Comment | 08 Nov, 2018
Thermo Fisher Scientific Inc., the world leader in serving science, has elected Jim Mullen to its board of directors. Mu...Read more
-
NICE recommends Vyxeos for specific secondary AML
World | News | 0 Comment | 08 Nov, 2018
Jazz Pharmaceuticals plc announced that the National Institute for Health and Care Excellence (NICE) has publ...Read more
-
AbbVie announces global patent license with Momenta
World | News | 0 Comment | 07 Nov, 2018
AbbVie has announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under the t...Read more
-
Oncology Analytics raises $21M Series B financing led by Oak HC/FT
World | News | 0 Comment | 06 Nov, 2018
Oncology Analytics, a leading technology-enabled service company which provides health plans, providers and patients wit...Read more
